Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01845103Terminated

The PEARL 8.0 Post-Approval Study

Role: lead

NCT01827319Completed

Cardiogenesis Transmyocardial Revascularization Registry

Role: lead

NCT01285297Not ApplicableTerminated

Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction

Role: lead

NCT01287910Not ApplicableTerminated

Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging

Role: collaborator

All 4 trials loaded